Poly(ADP-ribose)polymerase 1 inhibition protects against age-dependent endothelial dysfunction

Area of Science:

• Cardiovascular Biology
• Aging Research
• Molecular Medicine

Background:

• Age-related endothelial dysfunction is linked to reactive oxygen species (ROS) and poly(ADP-ribose) polymerase 1 (PARP-1) activation.
• Oxidant-induced DNA damage activates PARP-1, contributing to endothelial dysfunction in various conditions.

Purpose of the Study:

• To investigate the role of PARP-1 in age-dependent endothelial cell dysfunction.
• To elucidate the underlying mechanisms of PARP-1's involvement in vascular aging.

Main Methods:

• Comparison of wild-type (WT) and PARP-1 knockout (PARP-1(-/-)) mice at young (2 months) and old (12 months) ages.
• Assessment of endothelial function via isometric tension recording of aortic rings.
• Measurement of nitric oxide (NO) and superoxide (O2(-)) production, and western blot analysis for key proteins (PARP-1, eNOS, iNOS, Arg2).

Main Results:

• Old WT mice exhibited impaired endothelium-dependent relaxation, unlike old PARP-1(-/-) mice.
• Increased superoxide production and upregulation of iNOS and arginase-2 were observed in aging WT mice.
• Reduced phosphorylation of eNOS (p-eNOS) occurred in aging WT mice, while eNOS expression remained unchanged.

Conclusions:

• PARP-1 plays a critical role in age-dependent endothelial dysfunction.
• Inhibition of PARP-1 may protect against vascular aging by modulating NO bioavailability, potentially via iNOS.
• Targeting PARP-1 offers a potential strategy for preventing vascular aging.